

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.62474372 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.55935420 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.55935420 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.25200276 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.25200276 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.25200276 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.25200276 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.25200276 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 6.25200276 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.78021368 |
| 11 | negative regulation of myotube differentiation (GO:0010832) | 5.73399568 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.61025091 |
| 13 | detection of other organism (GO:0098543) | 5.53696964 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.50977032 |
| 15 | detection of bacterium (GO:0016045) | 5.28292466 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.16276796 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 5.14796527 |
| 18 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.06517860 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.90095733 |
| 20 | presynaptic membrane assembly (GO:0097105) | 4.89988689 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 4.88769926 |
| 22 | leukocyte aggregation (GO:0070486) | 4.87518650 |
| 23 | detection of external biotic stimulus (GO:0098581) | 4.87168276 |
| 24 | neutrophil activation (GO:0042119) | 4.72499573 |
| 25 | cellular extravasation (GO:0045123) | 4.69829596 |
| 26 | response to interleukin-15 (GO:0070672) | 4.53560193 |
| 27 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.49527388 |
| 28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.46621760 |
| 29 | negative regulation of interleukin-12 production (GO:0032695) | 4.44671783 |
| 30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.42655870 |
| 31 | response to host immune response (GO:0052572) | 4.42655870 |
| 32 | endothelium development (GO:0003158) | 4.41568714 |
| 33 | postsynaptic membrane organization (GO:0001941) | 4.37910721 |
| 34 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.36736730 |
| 35 | granulocyte activation (GO:0036230) | 4.27664626 |
| 36 | facial nerve structural organization (GO:0021612) | 4.27270957 |
| 37 | detection of biotic stimulus (GO:0009595) | 4.22994954 |
| 38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.22097344 |
| 39 | cellular response to interleukin-15 (GO:0071350) | 4.20418281 |
| 40 | regulation of pigment cell differentiation (GO:0050932) | 4.14690140 |
| 41 | microglial cell activation (GO:0001774) | 4.12155754 |
| 42 | presynaptic membrane organization (GO:0097090) | 4.07931250 |
| 43 | neutrophil mediated immunity (GO:0002446) | 4.07564510 |
| 44 | regulation of gamma-delta T cell activation (GO:0046643) | 4.06588075 |
| 45 | response to host (GO:0075136) | 4.05606319 |
| 46 | response to host defenses (GO:0052200) | 4.05606319 |
| 47 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.05606319 |
| 48 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.00860972 |
| 49 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.90890395 |
| 50 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.89813833 |
| 51 | macrophage activation (GO:0042116) | 3.86529279 |
| 52 | immunoglobulin mediated immune response (GO:0016064) | 3.86307885 |
| 53 | respiratory chain complex IV assembly (GO:0008535) | 3.82944319 |
| 54 | myeloid cell activation involved in immune response (GO:0002275) | 3.80412693 |
| 55 | regulation of mast cell degranulation (GO:0043304) | 3.76051403 |
| 56 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 3.73050739 |
| 57 | cranial nerve morphogenesis (GO:0021602) | 3.71135923 |
| 58 | protein heterotetramerization (GO:0051290) | 3.66925738 |
| 59 | superoxide anion generation (GO:0042554) | 3.59136469 |
| 60 | type I interferon signaling pathway (GO:0060337) | 3.58666872 |
| 61 | cellular response to type I interferon (GO:0071357) | 3.58666872 |
| 62 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.56405083 |
| 63 | response to type I interferon (GO:0034340) | 3.56016926 |
| 64 | negative regulation of T cell mediated immunity (GO:0002710) | 3.53983915 |
| 65 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.49961630 |
| 66 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.46815515 |
| 67 | myeloid leukocyte mediated immunity (GO:0002444) | 3.46281384 |
| 68 | cytochrome complex assembly (GO:0017004) | 3.45839519 |
| 69 | lymphoid progenitor cell differentiation (GO:0002320) | 3.44854661 |
| 70 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.44804853 |
| 71 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.44038609 |
| 72 | leukocyte degranulation (GO:0043299) | 3.40106446 |
| 73 | positive regulation of mast cell activation (GO:0033005) | 3.39717424 |
| 74 | negative regulation of phagocytosis (GO:0050765) | 3.39585581 |
| 75 | short-term memory (GO:0007614) | 3.39222433 |
| 76 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.38515119 |
| 77 | response to folic acid (GO:0051593) | 3.33192537 |
| 78 | germinal center formation (GO:0002467) | 3.31712285 |
| 79 | regulation of leukocyte degranulation (GO:0043300) | 3.30269265 |
| 80 | DNA ligation (GO:0006266) | 3.29678901 |
| 81 | regulation of T cell tolerance induction (GO:0002664) | 3.29206110 |
| 82 | B cell receptor signaling pathway (GO:0050853) | 3.29038484 |
| 83 | regulation of mast cell activation (GO:0033003) | 3.27978524 |
| 84 | cranial nerve structural organization (GO:0021604) | 3.27864179 |
| 85 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.27503466 |
| 86 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.27503466 |
| 87 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.27489646 |
| 88 | DNA deamination (GO:0045006) | 3.24586602 |
| 89 | dendritic cell migration (GO:0036336) | 3.23905009 |
| 90 | regulation of tolerance induction (GO:0002643) | 3.23699011 |
| 91 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.20771940 |
| 92 | defense response to protozoan (GO:0042832) | 3.19196142 |
| 93 | regulation of B cell differentiation (GO:0045577) | 3.18572693 |
| 94 | omega-hydroxylase P450 pathway (GO:0097267) | 3.15663702 |
| 95 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.14240287 |
| 96 | amino sugar catabolic process (GO:0046348) | 3.14088264 |
| 97 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.11539871 |
| 98 | negative regulation of interleukin-6 production (GO:0032715) | 3.10569410 |
| 99 | B cell mediated immunity (GO:0019724) | 3.08853097 |
| 100 | response to muramyl dipeptide (GO:0032495) | 3.08748605 |
| 101 | neutrophil chemotaxis (GO:0030593) | 3.05532715 |
| 102 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.05284478 |
| 103 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.03948966 |
| 104 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.03140717 |
| 105 | developmental pigmentation (GO:0048066) | 3.02415176 |
| 106 | proteasome assembly (GO:0043248) | 3.02192595 |
| 107 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.01226694 |
| 108 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.01226694 |
| 109 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.99377492 |
| 110 | negative regulation of type 2 immune response (GO:0002829) | 2.98983344 |
| 111 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.98432988 |
| 112 | regulation of regulated secretory pathway (GO:1903305) | 2.98031555 |
| 113 | neutrophil migration (GO:1990266) | 2.97782249 |
| 114 | ribosomal small subunit biogenesis (GO:0042274) | 2.97591165 |
| 115 | myeloid leukocyte activation (GO:0002274) | 2.95864691 |
| 116 | mesonephros development (GO:0001823) | 2.94432269 |
| 117 | positive regulation of B cell differentiation (GO:0045579) | 2.93629351 |
| 118 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.93284513 |
| 119 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.93284513 |
| 120 | positive regulation of interferon-alpha production (GO:0032727) | 2.92298774 |
| 121 | negative regulation of innate immune response (GO:0045824) | 2.91291589 |
| 122 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.91161218 |
| 123 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.90865634 |
| 124 | positive regulation of mast cell degranulation (GO:0043306) | 2.90865634 |
| 125 | androgen biosynthetic process (GO:0006702) | 2.87704248 |
| 126 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.85102766 |
| 127 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.84592047 |
| 128 | termination of RNA polymerase III transcription (GO:0006386) | 2.84592047 |
| 129 | mannosylation (GO:0097502) | 2.84254845 |
| 130 | neuronal action potential propagation (GO:0019227) | 2.82916425 |
| 131 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.80772743 |
| 132 | melanin metabolic process (GO:0006582) | 2.78496446 |
| 133 | keratinocyte development (GO:0003334) | 2.76854752 |
| 134 | negative regulation of metanephros development (GO:0072217) | 2.74484262 |
| 135 | negative regulation of striated muscle cell differentiation (GO:0051154) | 2.72431696 |
| 136 | GPI anchor biosynthetic process (GO:0006506) | 2.71696045 |
| 137 | sphingoid metabolic process (GO:0046519) | 2.70161108 |
| 138 | viral transcription (GO:0019083) | 2.69462619 |
| 139 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.69071906 |
| 140 | mature B cell differentiation (GO:0002335) | 2.68335542 |
| 141 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.66753379 |
| 142 | pattern specification involved in kidney development (GO:0061004) | 2.65158495 |
| 143 | N-acetylneuraminate metabolic process (GO:0006054) | 2.64313981 |
| 144 | cotranslational protein targeting to membrane (GO:0006613) | 2.63466257 |
| 145 | regulation of timing of cell differentiation (GO:0048505) | 2.63199431 |
| 146 | negative regulation of muscle cell differentiation (GO:0051148) | 2.63082313 |
| 147 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.62175165 |
| 148 | protein targeting to ER (GO:0045047) | 2.59722339 |
| 149 | sympathetic nervous system development (GO:0048485) | 2.59535256 |
| 150 | nucleoside diphosphate catabolic process (GO:0009134) | 2.56466473 |
| 151 | signal peptide processing (GO:0006465) | 2.55619517 |
| 152 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.54670725 |
| 153 | generation of neurons (GO:0048699) | 2.54249823 |
| 154 | righting reflex (GO:0060013) | 2.54103317 |
| 155 | viral genome replication (GO:0019079) | 2.51610976 |
| 156 | response to increased oxygen levels (GO:0036296) | 2.50963948 |
| 157 | response to hyperoxia (GO:0055093) | 2.50963948 |
| 158 | parturition (GO:0007567) | 2.50478852 |
| 159 | glucosamine-containing compound catabolic process (GO:1901072) | 2.49399264 |
| 160 | translational termination (GO:0006415) | 2.48653203 |
| 161 | protein localization to endoplasmic reticulum (GO:0070972) | 2.48056784 |
| 162 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.48036595 |
| 163 | response to peptidoglycan (GO:0032494) | 2.47808284 |
| 164 | negative regulation of anoikis (GO:2000811) | 2.47288098 |
| 165 | protein complex biogenesis (GO:0070271) | 2.47136579 |
| 166 | regulation of male gonad development (GO:2000018) | 2.46572353 |
| 167 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.45248313 |
| 168 | Rap protein signal transduction (GO:0032486) | 2.44497549 |
| 169 | C-terminal protein lipidation (GO:0006501) | 2.44165550 |
| 170 | regulation of interleukin-8 secretion (GO:2000482) | 2.43892504 |
| 171 | mature B cell differentiation involved in immune response (GO:0002313) | 2.41913768 |
| 172 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.41509048 |
| 173 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.37702523 |
| 174 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.36857449 |
| 175 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.36728076 |
| 176 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.35412151 |
| 177 | dendritic cell chemotaxis (GO:0002407) | 2.34784519 |
| 178 | GTP biosynthetic process (GO:0006183) | 2.34717878 |
| 179 | neuron cell-cell adhesion (GO:0007158) | 2.34622553 |
| 180 | regulation of development, heterochronic (GO:0040034) | 2.33065262 |
| 181 | nephron epithelium development (GO:0072009) | 2.31221595 |
| 182 | regulation of G0 to G1 transition (GO:0070316) | 2.29515537 |
| 183 | cell differentiation involved in metanephros development (GO:0072202) | 2.28968481 |
| 184 | platelet dense granule organization (GO:0060155) | 2.27298227 |
| 185 | mast cell activation (GO:0045576) | 2.26910254 |
| 186 | neutrophil activation involved in immune response (GO:0002283) | 2.26481584 |
| 187 | DNA integration (GO:0015074) | 2.26140085 |
| 188 | negative regulation of gluconeogenesis (GO:0045721) | 2.25438675 |
| 189 | GPI anchor metabolic process (GO:0006505) | 2.23734977 |
| 190 | negative regulation of norepinephrine secretion (GO:0010700) | 2.23419666 |
| 191 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.22377317 |
| 192 | membrane invagination (GO:0010324) | 2.21165024 |
| 193 | positive regulation of protein kinase C signaling (GO:0090037) | 2.20948224 |
| 194 | regulation of smooth muscle cell differentiation (GO:0051150) | 2.20156997 |
| 195 | GMP metabolic process (GO:0046037) | 2.19680452 |
| 196 | respiratory burst (GO:0045730) | 2.19541027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.32765751 |
| 2 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.95510091 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.83299566 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.80230058 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.76982944 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.46786626 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.21275218 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.19188123 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.15956033 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.87719194 |
| 11 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.86092316 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.84310585 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76517583 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.75496760 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.74093942 |
| 16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.71887134 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.69434461 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.66943253 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.61445355 |
| 20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.60864571 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.50951964 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.50277509 |
| 23 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.48755250 |
| 24 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.46704749 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.44537894 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.42602831 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 2.40947241 |
| 28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.38574718 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.31152060 |
| 30 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.28194737 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 2.27997999 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.25891091 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.25786798 |
| 34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.25388363 |
| 35 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.23518115 |
| 36 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.20721282 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 2.20637724 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.15081370 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.14504161 |
| 40 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.13958828 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12864992 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.11289052 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.06607154 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.99904302 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.98892184 |
| 46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.97373387 |
| 47 | MYC_22102868_ChIP-Seq_BL_Human | 1.97302672 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96192358 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.95864661 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.92727289 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92315362 |
| 52 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.88206625 |
| 53 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.86243756 |
| 54 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.82730082 |
| 55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.80933639 |
| 56 | MAF_26560356_Chip-Seq_TH2_Human | 1.79110661 |
| 57 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.77074851 |
| 58 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.75736925 |
| 59 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.75643298 |
| 60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73267528 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.72550793 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.71428369 |
| 63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.70989146 |
| 64 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.70155924 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.70070242 |
| 66 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.69328550 |
| 67 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69214334 |
| 68 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.68167991 |
| 69 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.68076699 |
| 70 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.66534320 |
| 71 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.66258230 |
| 72 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.66258230 |
| 73 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.63186549 |
| 74 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62576202 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.60376596 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58740868 |
| 77 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.58430215 |
| 78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.57934881 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.55775175 |
| 80 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.55422429 |
| 81 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.53324783 |
| 82 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52101620 |
| 83 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.51848692 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.50996791 |
| 85 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.50289974 |
| 86 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50181526 |
| 87 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.48931521 |
| 88 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.48622593 |
| 89 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.45341370 |
| 90 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.45165799 |
| 91 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.45152248 |
| 92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44567628 |
| 93 | VDR_22108803_ChIP-Seq_LS180_Human | 1.42624308 |
| 94 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.42534735 |
| 95 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.42516348 |
| 96 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.41762493 |
| 97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41383091 |
| 98 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.41241001 |
| 99 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.39480156 |
| 100 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.39326986 |
| 101 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39081058 |
| 102 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39063837 |
| 103 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.39052382 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39045163 |
| 105 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38485141 |
| 106 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37902694 |
| 107 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.37596169 |
| 108 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34076939 |
| 109 | P300_19829295_ChIP-Seq_ESCs_Human | 1.33341007 |
| 110 | GATA3_26560356_Chip-Seq_TH2_Human | 1.33015131 |
| 111 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.32818758 |
| 112 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30802396 |
| 113 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.30456782 |
| 114 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.28615381 |
| 115 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27881020 |
| 116 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.27032579 |
| 117 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26468358 |
| 118 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.25752536 |
| 119 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25741489 |
| 120 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.25609545 |
| 121 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25068556 |
| 122 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24152868 |
| 123 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23859964 |
| 124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23137478 |
| 125 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22919893 |
| 126 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22338671 |
| 127 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.21690901 |
| 128 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21456301 |
| 129 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.20966735 |
| 130 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.19766890 |
| 131 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.19621261 |
| 132 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19395041 |
| 133 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.19024835 |
| 134 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18828070 |
| 135 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17893965 |
| 136 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16010650 |
| 137 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.15946731 |
| 138 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15837538 |
| 139 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.15756252 |
| 140 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15619311 |
| 141 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.15340573 |
| 142 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.14872909 |
| 143 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.14246422 |
| 144 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.13888727 |
| 145 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13594349 |
| 146 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.12826863 |
| 147 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.12826863 |
| 148 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.12826863 |
| 149 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.12094195 |
| 150 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.11965567 |
| 151 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11128173 |
| 152 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.11100686 |
| 153 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.10841336 |
| 154 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10829578 |
| 155 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10706300 |
| 156 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.10494812 |
| 157 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.08500670 |
| 158 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08365069 |
| 159 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.08071475 |
| 160 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.06622410 |
| 161 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05799470 |
| 162 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05385997 |
| 163 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.04970786 |
| 164 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.04861759 |
| 165 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.04374665 |
| 166 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03923173 |
| 167 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01578172 |
| 168 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01462345 |
| 169 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.99330781 |
| 170 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99291647 |
| 171 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99161595 |
| 172 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96426801 |
| 173 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96194785 |
| 174 | KDM2B_26808549_Chip-Seq_REH_Human | 0.96006743 |
| 175 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95527117 |
| 176 | FUS_26573619_Chip-Seq_HEK293_Human | 0.94272163 |
| 177 | EWS_26573619_Chip-Seq_HEK293_Human | 0.92796655 |
| 178 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92458118 |
| 179 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91526910 |
| 180 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91449208 |
| 181 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.89745287 |
| 182 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.89709180 |
| 183 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88395673 |
| 184 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86502010 |
| 185 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83097417 |
| 186 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.83036842 |
| 187 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.77180893 |
| 188 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.75909020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 5.87566951 |
| 2 | MP0003136_yellow_coat_color | 5.05317128 |
| 3 | MP0001188_hyperpigmentation | 4.61123360 |
| 4 | MP0003724_increased_susceptibility_to | 3.89974131 |
| 5 | MP0005409_darkened_coat_color | 3.38023190 |
| 6 | MP0004381_abnormal_hair_follicle | 3.29506727 |
| 7 | MP0006292_abnormal_olfactory_placode | 3.16263545 |
| 8 | MP0000015_abnormal_ear_pigmentation | 3.12321886 |
| 9 | MP0005174_abnormal_tail_pigmentation | 2.87170221 |
| 10 | MP0001790_abnormal_immune_system | 2.81004333 |
| 11 | MP0005387_immune_system_phenotype | 2.81004333 |
| 12 | MP0003880_abnormal_central_pattern | 2.80682033 |
| 13 | MP0000685_abnormal_immune_system | 2.75892629 |
| 14 | MP0006082_CNS_inflammation | 2.60192215 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.52546256 |
| 16 | MP0000372_irregular_coat_pigmentation | 2.44566861 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.38341557 |
| 18 | MP0001986_abnormal_taste_sensitivity | 2.33081313 |
| 19 | MP0001533_abnormal_skeleton_physiology | 2.29443598 |
| 20 | MP0005171_absent_coat_pigmentation | 2.19840828 |
| 21 | MP0002405_respiratory_system_inflammati | 2.08442045 |
| 22 | MP0003303_peritoneal_inflammation | 2.04973041 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.02143926 |
| 24 | MP0002398_abnormal_bone_marrow | 1.91481682 |
| 25 | MP0002102_abnormal_ear_morphology | 1.88434243 |
| 26 | MP0000716_abnormal_immune_system | 1.88161755 |
| 27 | MP0006276_abnormal_autonomic_nervous | 1.81829943 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.79179216 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.77476107 |
| 30 | MP0002396_abnormal_hematopoietic_system | 1.73775654 |
| 31 | MP0009278_abnormal_bone_marrow | 1.71659673 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.71206725 |
| 33 | MP0003866_abnormal_defecation | 1.71057477 |
| 34 | MP0002095_abnormal_skin_pigmentation | 1.68169599 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.66386069 |
| 36 | MP0008260_abnormal_autophagy | 1.64486444 |
| 37 | MP0005075_abnormal_melanosome_morpholog | 1.60797400 |
| 38 | MP0004947_skin_inflammation | 1.58442232 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.58405422 |
| 40 | MP0009764_decreased_sensitivity_to | 1.57554419 |
| 41 | MP0002722_abnormal_immune_system | 1.57389403 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.55237045 |
| 43 | MP0002148_abnormal_hypersensitivity_rea | 1.55131733 |
| 44 | MP0005451_abnormal_body_composition | 1.52401099 |
| 45 | MP0002429_abnormal_blood_cell | 1.48361754 |
| 46 | MP0008469_abnormal_protein_level | 1.48175410 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.47592611 |
| 48 | MP0009785_altered_susceptibility_to | 1.46354298 |
| 49 | MP0004883_abnormal_blood_vessel | 1.44039100 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.43711073 |
| 51 | MP0004742_abnormal_vestibular_system | 1.42264064 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.41459126 |
| 53 | MP0002009_preneoplasia | 1.36846570 |
| 54 | MP0002177_abnormal_outer_ear | 1.36705240 |
| 55 | MP0000681_abnormal_thyroid_gland | 1.32862653 |
| 56 | MP0003075_altered_response_to | 1.32535886 |
| 57 | MP0000858_altered_metastatic_potential | 1.31519903 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.31406149 |
| 59 | MP0005671_abnormal_response_to | 1.31251118 |
| 60 | MP0005310_abnormal_salivary_gland | 1.30360928 |
| 61 | MP0004510_myositis | 1.29448945 |
| 62 | MP0001851_eye_inflammation | 1.27319709 |
| 63 | MP0001661_extended_life_span | 1.24507760 |
| 64 | MP0000049_abnormal_middle_ear | 1.21251056 |
| 65 | MP0002163_abnormal_gland_morphology | 1.20970219 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 1.20618080 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.20618080 |
| 68 | MP0000566_synostosis | 1.18199045 |
| 69 | MP0001835_abnormal_antigen_presentation | 1.16763424 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.12998549 |
| 71 | MP0005000_abnormal_immune_tolerance | 1.11952741 |
| 72 | MP0009697_abnormal_copulation | 1.08776984 |
| 73 | MP0003941_abnormal_skin_development | 1.08306706 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 1.06150517 |
| 75 | MP0002938_white_spotting | 1.04371175 |
| 76 | MP0004142_abnormal_muscle_tone | 1.02862881 |
| 77 | MP0003938_abnormal_ear_development | 1.02286218 |
| 78 | MP0000613_abnormal_salivary_gland | 1.01976396 |
| 79 | MP0003690_abnormal_glial_cell | 1.00381016 |
| 80 | MP0000026_abnormal_inner_ear | 0.99521165 |
| 81 | MP0001968_abnormal_touch/_nociception | 0.98949409 |
| 82 | MP0003879_abnormal_hair_cell | 0.97737648 |
| 83 | MP0002419_abnormal_innate_immunity | 0.97723073 |
| 84 | MP0001905_abnormal_dopamine_level | 0.97707349 |
| 85 | MP0005645_abnormal_hypothalamus_physiol | 0.96221203 |
| 86 | MP0001663_abnormal_digestive_system | 0.95383640 |
| 87 | MP0005166_decreased_susceptibility_to | 0.95127210 |
| 88 | MP0005248_abnormal_Harderian_gland | 0.94904697 |
| 89 | MP0005595_abnormal_vascular_smooth | 0.94440522 |
| 90 | MP0003045_fibrosis | 0.94312500 |
| 91 | MP0002249_abnormal_larynx_morphology | 0.93411205 |
| 92 | MP0005390_skeleton_phenotype | 0.93186745 |
| 93 | MP0005025_abnormal_response_to | 0.92578506 |
| 94 | MP0005379_endocrine/exocrine_gland_phen | 0.92201470 |
| 95 | MP0003878_abnormal_ear_physiology | 0.92181169 |
| 96 | MP0005377_hearing/vestibular/ear_phenot | 0.92181169 |
| 97 | MP0001919_abnormal_reproductive_system | 0.89962679 |
| 98 | MP0001346_abnormal_lacrimal_gland | 0.87903796 |
| 99 | MP0003011_delayed_dark_adaptation | 0.87664911 |
| 100 | MP0000490_abnormal_crypts_of | 0.87576846 |
| 101 | MP0002751_abnormal_autonomic_nervous | 0.87518938 |
| 102 | MP0003828_pulmonary_edema | 0.87117555 |
| 103 | MP0003763_abnormal_thymus_physiology | 0.86729300 |
| 104 | MP0008004_abnormal_stomach_pH | 0.86688675 |
| 105 | MP0003448_altered_tumor_morphology | 0.86305024 |
| 106 | MP0009763_increased_sensitivity_to | 0.85413880 |
| 107 | MP0000631_abnormal_neuroendocrine_gland | 0.85214880 |
| 108 | MP0010386_abnormal_urinary_bladder | 0.82995863 |
| 109 | MP0002132_abnormal_respiratory_system | 0.82574409 |
| 110 | MP0003436_decreased_susceptibility_to | 0.81848757 |
| 111 | MP0002166_altered_tumor_susceptibility | 0.81434577 |
| 112 | MP0002723_abnormal_immune_serum | 0.80839866 |
| 113 | MP0001486_abnormal_startle_reflex | 0.79763768 |
| 114 | MP0004272_abnormal_basement_membrane | 0.79654906 |
| 115 | MP0001502_abnormal_circadian_rhythm | 0.79539053 |
| 116 | MP0003806_abnormal_nucleotide_metabolis | 0.79033456 |
| 117 | MP0001963_abnormal_hearing_physiology | 0.78529327 |
| 118 | MP0003786_premature_aging | 0.78495595 |
| 119 | MP0002067_abnormal_sensory_capabilities | 0.78328193 |
| 120 | MP0005084_abnormal_gallbladder_morpholo | 0.78211264 |
| 121 | MP0002557_abnormal_social/conspecific_i | 0.77762767 |
| 122 | MP0009250_abnormal_appendicular_skeleto | 0.77125012 |
| 123 | MP0003656_abnormal_erythrocyte_physiolo | 0.76900302 |
| 124 | MP0002933_joint_inflammation | 0.76471753 |
| 125 | MP0002420_abnormal_adaptive_immunity | 0.75937084 |
| 126 | MP0001819_abnormal_immune_cell | 0.75296327 |
| 127 | MP0002452_abnormal_antigen_presenting | 0.74305869 |
| 128 | MP0001542_abnormal_bone_strength | 0.73586163 |
| 129 | MP0002272_abnormal_nervous_system | 0.73341655 |
| 130 | MP0009765_abnormal_xenobiotic_induced | 0.73063791 |
| 131 | MP0003385_abnormal_body_wall | 0.73062518 |
| 132 | MP0003315_abnormal_perineum_morphology | 0.72798686 |
| 133 | MP0003221_abnormal_cardiomyocyte_apopto | 0.72233195 |
| 134 | MP0001873_stomach_inflammation | 0.71972631 |
| 135 | MP0005083_abnormal_biliary_tract | 0.71226164 |
| 136 | MP0005381_digestive/alimentary_phenotyp | 0.70617069 |
| 137 | MP0002160_abnormal_reproductive_system | 0.69741035 |
| 138 | MP0004858_abnormal_nervous_system | 0.69698303 |
| 139 | MP0004808_abnormal_hematopoietic_stem | 0.67140300 |
| 140 | MP0004147_increased_porphyrin_level | 0.66994729 |
| 141 | MP0005164_abnormal_response_to | 0.66347491 |
| 142 | MP0008874_decreased_physiological_sensi | 0.65596674 |
| 143 | MP0004130_abnormal_muscle_cell | 0.65550963 |
| 144 | MP0002138_abnormal_hepatobiliary_system | 0.65427933 |
| 145 | MP0001485_abnormal_pinna_reflex | 0.64930620 |
| 146 | MP0000920_abnormal_myelination | 0.63902998 |
| 147 | MP0005551_abnormal_eye_electrophysiolog | 0.62844049 |
| 148 | MP0003795_abnormal_bone_structure | 0.62821433 |
| 149 | MP0000604_amyloidosis | 0.62716684 |
| 150 | MP0002736_abnormal_nociception_after | 0.62627693 |
| 151 | MP0001800_abnormal_humoral_immune | 0.62552075 |
| 152 | MP0009745_abnormal_behavioral_response | 0.62533888 |
| 153 | MP0001186_pigmentation_phenotype | 0.61485416 |
| 154 | MP0002928_abnormal_bile_duct | 0.60940523 |
| 155 | MP0005058_abnormal_lysosome_morphology | 0.60769305 |
| 156 | MP0001664_abnormal_digestion | 0.60733811 |
| 157 | MP0003646_muscle_fatigue | 0.59219960 |
| 158 | MP0002332_abnormal_exercise_endurance | 0.59213588 |
| 159 | MP0005165_increased_susceptibility_to | 0.59182416 |
| 160 | MP0008995_early_reproductive_senescence | 0.59154491 |
| 161 | MP0005319_abnormal_enzyme/_coenzyme | 0.59076277 |
| 162 | MP0000249_abnormal_blood_vessel | 0.58249234 |
| 163 | MP0002133_abnormal_respiratory_system | 0.55659772 |
| 164 | MP0005388_respiratory_system_phenotype | 0.55659772 |
| 165 | MP0000343_altered_response_to | 0.55361785 |
| 166 | MP0001853_heart_inflammation | 0.55244614 |
| 167 | MP0001958_emphysema | 0.51781796 |
| 168 | MP0002653_abnormal_ependyma_morphology | 0.46403044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.21835631 |
| 2 | Myositis (HP:0100614) | 6.35553285 |
| 3 | Orchitis (HP:0100796) | 6.07663780 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.69378590 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 5.63892480 |
| 6 | Optic neuritis (HP:0100653) | 5.63892480 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.39065450 |
| 8 | Reduced antithrombin III activity (HP:0001976) | 5.25893753 |
| 9 | Hypochromic microcytic anemia (HP:0004840) | 5.10158914 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.78799959 |
| 11 | Type I transferrin isoform profile (HP:0003642) | 4.71932763 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 4.59849882 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.24295308 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 4.23452455 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.15880845 |
| 16 | Keratoconjunctivitis sicca (HP:0001097) | 4.12519812 |
| 17 | Hypochromic anemia (HP:0001931) | 4.05032884 |
| 18 | Encephalitis (HP:0002383) | 3.89997388 |
| 19 | Keratoconjunctivitis (HP:0001096) | 3.82425555 |
| 20 | Spontaneous hematomas (HP:0007420) | 3.80736914 |
| 21 | Increased IgE level (HP:0003212) | 3.79627674 |
| 22 | Gingivitis (HP:0000230) | 3.78410976 |
| 23 | Urticaria (HP:0001025) | 3.76305314 |
| 24 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.64488101 |
| 25 | Vasculitis (HP:0002633) | 3.51732009 |
| 26 | Episodic fever (HP:0001954) | 3.45261292 |
| 27 | Chest pain (HP:0100749) | 3.36304911 |
| 28 | Peritonitis (HP:0002586) | 3.34886259 |
| 29 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.28317917 |
| 30 | Abnormal protein glycosylation (HP:0012346) | 3.26722539 |
| 31 | Abnormal glycosylation (HP:0012345) | 3.26722539 |
| 32 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.26722539 |
| 33 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.26722539 |
| 34 | Cellulitis (HP:0100658) | 3.25590154 |
| 35 | Renal Fanconi syndrome (HP:0001994) | 3.22124792 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 3.20156113 |
| 37 | Obstructive lung disease (HP:0006536) | 3.20156113 |
| 38 | 3-Methylglutaconic aciduria (HP:0003535) | 3.19129201 |
| 39 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.17181969 |
| 40 | Hypothermia (HP:0002045) | 3.11977408 |
| 41 | Increased hepatocellular lipid droplets (HP:0006565) | 3.09011820 |
| 42 | Hemoptysis (HP:0002105) | 3.08388568 |
| 43 | Gingival bleeding (HP:0000225) | 3.04292367 |
| 44 | Anorexia (HP:0002039) | 3.03942190 |
| 45 | T lymphocytopenia (HP:0005403) | 2.99410411 |
| 46 | Exertional dyspnea (HP:0002875) | 2.95254912 |
| 47 | Pulmonary infiltrates (HP:0002113) | 2.93565679 |
| 48 | Abnormality of T cell number (HP:0011839) | 2.93119719 |
| 49 | Arterial thrombosis (HP:0004420) | 2.89866895 |
| 50 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.82761908 |
| 51 | Leukocytosis (HP:0001974) | 2.81026965 |
| 52 | Patchy hypopigmentation of hair (HP:0011365) | 2.79503354 |
| 53 | Nonprogressive disorder (HP:0003680) | 2.79276626 |
| 54 | Pulmonary embolism (HP:0002204) | 2.79180553 |
| 55 | Stomatitis (HP:0010280) | 2.74135132 |
| 56 | Epistaxis (HP:0000421) | 2.73206205 |
| 57 | Septo-optic dysplasia (HP:0100842) | 2.69427944 |
| 58 | Inflammation of the large intestine (HP:0002037) | 2.65385177 |
| 59 | Increased IgM level (HP:0003496) | 2.65107203 |
| 60 | Amyloidosis (HP:0011034) | 2.64315045 |
| 61 | Osteomyelitis (HP:0002754) | 2.59308580 |
| 62 | Abnormality of T cells (HP:0002843) | 2.59272649 |
| 63 | Pustule (HP:0200039) | 2.59127191 |
| 64 | White forelock (HP:0002211) | 2.56292193 |
| 65 | Gastrointestinal inflammation (HP:0004386) | 2.55686921 |
| 66 | Sex reversal (HP:0012245) | 2.54983318 |
| 67 | Abnormal sex determination (HP:0012244) | 2.54983318 |
| 68 | Abnormality of dental color (HP:0011073) | 2.52957961 |
| 69 | Granulocytopenia (HP:0001913) | 2.49448913 |
| 70 | Microvesicular hepatic steatosis (HP:0001414) | 2.48217734 |
| 71 | Abnormality of secondary sexual hair (HP:0009888) | 2.48001597 |
| 72 | Abnormality of the axillary hair (HP:0100134) | 2.48001597 |
| 73 | Congenital sensorineural hearing impairment (HP:0008527) | 2.47551885 |
| 74 | Sepsis (HP:0100806) | 2.47306650 |
| 75 | Abnormality of renal resorption (HP:0011038) | 2.46460497 |
| 76 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.46239219 |
| 77 | Gangrene (HP:0100758) | 2.46041155 |
| 78 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.44027788 |
| 79 | Abnormality of the pleura (HP:0002103) | 2.43675776 |
| 80 | Recurrent viral infections (HP:0004429) | 2.42270974 |
| 81 | Parakeratosis (HP:0001036) | 2.40524368 |
| 82 | Lipid accumulation in hepatocytes (HP:0006561) | 2.38918710 |
| 83 | Abnormality of the peritoneum (HP:0002585) | 2.38632114 |
| 84 | Reticulocytopenia (HP:0001896) | 2.36412666 |
| 85 | Thyroid-stimulating hormone excess (HP:0002925) | 2.35562522 |
| 86 | Severe visual impairment (HP:0001141) | 2.35210717 |
| 87 | Optic nerve hypoplasia (HP:0000609) | 2.33622489 |
| 88 | Attenuation of retinal blood vessels (HP:0007843) | 2.32143173 |
| 89 | Panhypogammaglobulinemia (HP:0003139) | 2.31737179 |
| 90 | Abnormality of the septum pellucidum (HP:0007375) | 2.31039786 |
| 91 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.30681137 |
| 92 | Lymphopenia (HP:0001888) | 2.27849384 |
| 93 | Absent septum pellucidum (HP:0001331) | 2.27065297 |
| 94 | Dry hair (HP:0011359) | 2.25272891 |
| 95 | Hypergammaglobulinemia (HP:0010702) | 2.23425819 |
| 96 | Abnormality of the endocardium (HP:0004306) | 2.22477294 |
| 97 | Abnormality of T cell physiology (HP:0011840) | 2.22277341 |
| 98 | Abnormality of the pericardium (HP:0001697) | 2.20440072 |
| 99 | Recurrent bacterial skin infections (HP:0005406) | 2.19846018 |
| 100 | Toxemia of pregnancy (HP:0100603) | 2.19722254 |
| 101 | Split foot (HP:0001839) | 2.18279838 |
| 102 | Abnormal platelet volume (HP:0011876) | 2.15906427 |
| 103 | Focal motor seizures (HP:0011153) | 2.15834260 |
| 104 | Short tibia (HP:0005736) | 2.15752655 |
| 105 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.15698562 |
| 106 | Premature loss of primary teeth (HP:0006323) | 2.14983027 |
| 107 | Glomerulopathy (HP:0100820) | 2.14670091 |
| 108 | Abnormality of magnesium homeostasis (HP:0004921) | 2.14610954 |
| 109 | Recurrent abscess formation (HP:0002722) | 2.14309739 |
| 110 | Hepatosplenomegaly (HP:0001433) | 2.13028947 |
| 111 | Acne (HP:0001061) | 2.12912168 |
| 112 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.12359820 |
| 113 | Absent/shortened dynein arms (HP:0200106) | 2.12359820 |
| 114 | Keratitis (HP:0000491) | 2.10066849 |
| 115 | Skin ulcer (HP:0200042) | 2.09146320 |
| 116 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.08700131 |
| 117 | Mitochondrial inheritance (HP:0001427) | 2.06802192 |
| 118 | Purpura (HP:0000979) | 2.06270784 |
| 119 | Eosinophilia (HP:0001880) | 2.05034470 |
| 120 | Slow saccadic eye movements (HP:0000514) | 2.04014754 |
| 121 | Meningitis (HP:0001287) | 2.03817499 |
| 122 | Polycythemia (HP:0001901) | 2.03777625 |
| 123 | Microcytic anemia (HP:0001935) | 2.03437927 |
| 124 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.02932718 |
| 125 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.01589119 |
| 126 | Acute hepatic failure (HP:0006554) | 2.01581549 |
| 127 | Vertigo (HP:0002321) | 2.00352403 |
| 128 | Hepatocellular necrosis (HP:0001404) | 1.97945212 |
| 129 | Hypoplasia of the fovea (HP:0007750) | 1.97157274 |
| 130 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.97157274 |
| 131 | Sparse eyelashes (HP:0000653) | 1.96799040 |
| 132 | Metaphyseal cupping (HP:0003021) | 1.96486054 |
| 133 | Abnormality of iron homeostasis (HP:0011031) | 1.96094551 |
| 134 | Difficulty running (HP:0009046) | 1.95054118 |
| 135 | Recurrent pneumonia (HP:0006532) | 1.93223612 |
| 136 | Chronic otitis media (HP:0000389) | 1.93034430 |
| 137 | Increased serum ferritin (HP:0003281) | 1.92519260 |
| 138 | Amelogenesis imperfecta (HP:0000705) | 1.91881268 |
| 139 | Optic disc pallor (HP:0000543) | 1.91665234 |
| 140 | Obstructive sleep apnea (HP:0002870) | 1.90861629 |
| 141 | Abnormal number of erythroid precursors (HP:0012131) | 1.90551720 |
| 142 | Vacuolated lymphocytes (HP:0001922) | 1.89416822 |
| 143 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.89404060 |
| 144 | Prolonged bleeding time (HP:0003010) | 1.88152097 |
| 145 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.87229185 |
| 146 | IgM deficiency (HP:0002850) | 1.87200561 |
| 147 | Subacute progressive viral hepatitis (HP:0006572) | 1.87030434 |
| 148 | Congenital, generalized hypertrichosis (HP:0004540) | 1.86429631 |
| 149 | Clubbing of toes (HP:0100760) | 1.86393341 |
| 150 | Concave nail (HP:0001598) | 1.86138573 |
| 151 | Hypergonadotropic hypogonadism (HP:0000815) | 1.85520521 |
| 152 | Prolonged partial thromboplastin time (HP:0003645) | 1.85353988 |
| 153 | Hypermelanotic macule (HP:0001034) | 1.85300045 |
| 154 | Abnormality of the prostate (HP:0008775) | 1.84730949 |
| 155 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.84489463 |
| 156 | Colitis (HP:0002583) | 1.83146118 |
| 157 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.82659534 |
| 158 | True hermaphroditism (HP:0010459) | 1.82342087 |
| 159 | Supernumerary spleens (HP:0009799) | 1.82108415 |
| 160 | Triphalangeal thumb (HP:0001199) | 1.81297927 |
| 161 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.80143546 |
| 162 | Skin rash (HP:0000988) | 1.79948643 |
| 163 | Cortical visual impairment (HP:0100704) | 1.79158911 |
| 164 | Flat occiput (HP:0005469) | 1.79065588 |
| 165 | Recurrent bronchitis (HP:0002837) | 1.78173748 |
| 166 | Viral hepatitis (HP:0006562) | 1.77792390 |
| 167 | Abnormal hemoglobin (HP:0011902) | 1.77747539 |
| 168 | Cheilitis (HP:0100825) | 1.76579009 |
| 169 | Progressive external ophthalmoplegia (HP:0000590) | 1.75772957 |
| 170 | Prolonged neonatal jaundice (HP:0006579) | 1.75475873 |
| 171 | Petechiae (HP:0000967) | 1.75247958 |
| 172 | Testicular atrophy (HP:0000029) | 1.74979443 |
| 173 | Abnormal ciliary motility (HP:0012262) | 1.74251156 |
| 174 | Abnormal pupillary function (HP:0007686) | 1.74008312 |
| 175 | Abnormality of placental membranes (HP:0011409) | 1.73344519 |
| 176 | Amniotic constriction ring (HP:0009775) | 1.73344519 |
| 177 | Nasolacrimal duct obstruction (HP:0000579) | 1.72954788 |
| 178 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.72884766 |
| 179 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.72884766 |
| 180 | Decreased central vision (HP:0007663) | 1.72817274 |
| 181 | Recurrent skin infections (HP:0001581) | 1.72590501 |
| 182 | Pallor (HP:0000980) | 1.72486326 |
| 183 | Macrocytic anemia (HP:0001972) | 1.71965792 |
| 184 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.69839479 |
| 185 | Recurrent cutaneous fungal infections (HP:0011370) | 1.69839479 |
| 186 | Prostate neoplasm (HP:0100787) | 1.66646442 |
| 187 | Hypomagnesemia (HP:0002917) | 1.65837037 |
| 188 | Increased intramyocellular lipid droplets (HP:0012240) | 1.64164740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.46368971 |
| 2 | TNIK | 4.04780576 |
| 3 | MKNK2 | 3.94100748 |
| 4 | MAP4K1 | 3.47407251 |
| 5 | MAP2K3 | 3.18664036 |
| 6 | EIF2AK3 | 3.08392480 |
| 7 | BLK | 3.05599609 |
| 8 | ERN1 | 3.05368771 |
| 9 | STK16 | 2.88254442 |
| 10 | FES | 2.81579795 |
| 11 | TYK2 | 2.71096323 |
| 12 | TLK1 | 2.62266732 |
| 13 | GRK6 | 2.53409548 |
| 14 | EPHB1 | 2.51085237 |
| 15 | NME2 | 2.48897771 |
| 16 | MKNK1 | 2.45210377 |
| 17 | IRAK3 | 2.40691175 |
| 18 | MUSK | 2.38149495 |
| 19 | IRAK4 | 2.36211051 |
| 20 | TAOK1 | 2.13669790 |
| 21 | MAP3K3 | 1.94205449 |
| 22 | MAP3K11 | 1.85654914 |
| 23 | NLK | 1.84610873 |
| 24 | CLK1 | 1.74049913 |
| 25 | JAK3 | 1.71676045 |
| 26 | PRPF4B | 1.70667077 |
| 27 | TEC | 1.68847583 |
| 28 | EIF2AK2 | 1.67527583 |
| 29 | PIM2 | 1.61698674 |
| 30 | MAP2K7 | 1.57729138 |
| 31 | YES1 | 1.52924854 |
| 32 | JAK2 | 1.50508014 |
| 33 | ADRBK2 | 1.49846359 |
| 34 | KSR2 | 1.47568404 |
| 35 | CAMKK2 | 1.45415982 |
| 36 | MAP3K12 | 1.44178687 |
| 37 | TXK | 1.40821943 |
| 38 | SIK3 | 1.38774005 |
| 39 | MAP3K1 | 1.35061385 |
| 40 | CDK19 | 1.33037482 |
| 41 | BMPR1B | 1.27628772 |
| 42 | MST4 | 1.26330356 |
| 43 | FER | 1.20770938 |
| 44 | GRK7 | 1.20698836 |
| 45 | IRAK1 | 1.20177643 |
| 46 | JAK1 | 1.17373560 |
| 47 | BMPR2 | 1.11796742 |
| 48 | PTK6 | 1.09688898 |
| 49 | MARK2 | 1.09291021 |
| 50 | EIF2AK1 | 1.09195196 |
| 51 | IRAK2 | 1.06430788 |
| 52 | CSK | 1.06373694 |
| 53 | MAPK13 | 1.01260731 |
| 54 | RIPK4 | 0.99501266 |
| 55 | SRPK1 | 0.99393158 |
| 56 | VRK1 | 0.99143714 |
| 57 | MAP3K13 | 0.99064689 |
| 58 | PRKD2 | 0.98093486 |
| 59 | CDK9 | 0.96925204 |
| 60 | ITK | 0.96094744 |
| 61 | CSF1R | 0.95607299 |
| 62 | KIT | 0.90105236 |
| 63 | SIK2 | 0.89813490 |
| 64 | CDK8 | 0.89758749 |
| 65 | MAP3K6 | 0.89028271 |
| 66 | MAP2K4 | 0.87635854 |
| 67 | MAP3K2 | 0.85976460 |
| 68 | MAP3K14 | 0.85958282 |
| 69 | TAOK2 | 0.85724907 |
| 70 | STK39 | 0.84735562 |
| 71 | PDK1 | 0.84228871 |
| 72 | TRIB3 | 0.83976604 |
| 73 | FGR | 0.82218659 |
| 74 | TESK2 | 0.81938150 |
| 75 | STK10 | 0.80686528 |
| 76 | PTK2B | 0.79424301 |
| 77 | SMG1 | 0.77989941 |
| 78 | MAPKAPK5 | 0.76487078 |
| 79 | BTK | 0.75921906 |
| 80 | LYN | 0.75622100 |
| 81 | PDPK1 | 0.75218449 |
| 82 | CAMK1 | 0.75001716 |
| 83 | FYN | 0.72695794 |
| 84 | LRRK2 | 0.72265341 |
| 85 | CDK3 | 0.71928399 |
| 86 | STK11 | 0.71859564 |
| 87 | MAP3K7 | 0.70971474 |
| 88 | PLK4 | 0.70817681 |
| 89 | GRK1 | 0.70203390 |
| 90 | EPHA3 | 0.67102453 |
| 91 | DAPK2 | 0.64005643 |
| 92 | PBK | 0.63973000 |
| 93 | DYRK1B | 0.63551594 |
| 94 | NEK9 | 0.62911899 |
| 95 | TGFBR2 | 0.62168390 |
| 96 | MAP3K5 | 0.61693501 |
| 97 | STK38 | 0.61680196 |
| 98 | TNK2 | 0.61679458 |
| 99 | PRKG2 | 0.60704763 |
| 100 | IKBKE | 0.60493928 |
| 101 | TAOK3 | 0.59131326 |
| 102 | RAF1 | 0.58078320 |
| 103 | CAMK2B | 0.57805609 |
| 104 | ADRBK1 | 0.57473596 |
| 105 | MAPK12 | 0.56625363 |
| 106 | PKN1 | 0.55087851 |
| 107 | CSNK1G1 | 0.54068558 |
| 108 | IKBKB | 0.52556661 |
| 109 | GRK5 | 0.52455312 |
| 110 | PRKCQ | 0.52291234 |
| 111 | NEK6 | 0.51799774 |
| 112 | MAPK4 | 0.51474928 |
| 113 | RET | 0.51348399 |
| 114 | SIK1 | 0.51121031 |
| 115 | KSR1 | 0.50594433 |
| 116 | NME1 | 0.49713406 |
| 117 | LCK | 0.49408996 |
| 118 | SGK3 | 0.49382265 |
| 119 | FGFR4 | 0.49333025 |
| 120 | MAP2K6 | 0.48627655 |
| 121 | SYK | 0.48250869 |
| 122 | FGFR3 | 0.47520886 |
| 123 | INSRR | 0.46890445 |
| 124 | CDC42BPA | 0.45781967 |
| 125 | PRKCE | 0.44604474 |
| 126 | ZAP70 | 0.44353817 |
| 127 | CAMK2A | 0.43208865 |
| 128 | UHMK1 | 0.43202433 |
| 129 | ZAK | 0.43051615 |
| 130 | PRKCZ | 0.42523783 |
| 131 | TIE1 | 0.42339643 |
| 132 | RPS6KL1 | 0.42105310 |
| 133 | RPS6KC1 | 0.42105310 |
| 134 | OXSR1 | 0.41297098 |
| 135 | HCK | 0.40868827 |
| 136 | MYLK | 0.40868590 |
| 137 | MAPK15 | 0.40466237 |
| 138 | MARK3 | 0.39776345 |
| 139 | ABL2 | 0.39207748 |
| 140 | MAPK7 | 0.39201737 |
| 141 | MAPKAPK2 | 0.38697293 |
| 142 | WNK4 | 0.37152656 |
| 143 | RPS6KA6 | 0.36916721 |
| 144 | CSNK1G3 | 0.36699038 |
| 145 | AKT3 | 0.36417109 |
| 146 | ALK | 0.36054272 |
| 147 | DYRK2 | 0.35558698 |
| 148 | DYRK1A | 0.35001073 |
| 149 | CAMK2D | 0.32509975 |
| 150 | WNK1 | 0.32379200 |
| 151 | CDK7 | 0.31501296 |
| 152 | TBK1 | 0.30884248 |
| 153 | DYRK3 | 0.30811214 |
| 154 | SGK2 | 0.30019175 |
| 155 | PRKCD | 0.29652165 |
| 156 | MATK | 0.29617531 |
| 157 | ABL1 | 0.29199617 |
| 158 | CAMKK1 | 0.28941111 |
| 159 | PIM1 | 0.28225028 |
| 160 | PIK3CG | 0.27381206 |
| 161 | BRAF | 0.27042299 |
| 162 | EPHA4 | 0.26708821 |
| 163 | CSNK1A1L | 0.26210194 |
| 164 | HIPK2 | 0.23925225 |
| 165 | PRKG1 | 0.23410506 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.20241039 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.15506358 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.85712821 |
| 4 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.30622733 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.23932179 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.20135430 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.18564871 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.01693529 |
| 9 | Basal transcription factors_Homo sapiens_hsa03022 | 1.96899836 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.94490020 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 1.91945800 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 1.84431438 |
| 13 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.82721361 |
| 14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.75991134 |
| 15 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.74338722 |
| 16 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.72145601 |
| 17 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.72114710 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.69853679 |
| 19 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.69517502 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.69280985 |
| 21 | DNA replication_Homo sapiens_hsa03030 | 1.64083833 |
| 22 | Phototransduction_Homo sapiens_hsa04744 | 1.60105582 |
| 23 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.60052948 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.59416434 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.55157381 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.53078394 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.50415631 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47377254 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.47257048 |
| 30 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.41793524 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41085878 |
| 32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.38350894 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.36869321 |
| 34 | Nicotine addiction_Homo sapiens_hsa05033 | 1.32072113 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.31941551 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.29611263 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 1.27064765 |
| 38 | Parkinsons disease_Homo sapiens_hsa05012 | 1.26699217 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.26084550 |
| 40 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.24523615 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24256103 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.19452926 |
| 43 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.18989689 |
| 44 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.17027967 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16616597 |
| 46 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.16111996 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.15397396 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 1.14465007 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.14364180 |
| 50 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.14226075 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 1.13161317 |
| 52 | Alzheimers disease_Homo sapiens_hsa05010 | 1.12612740 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11121573 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07473102 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.06633660 |
| 56 | Huntingtons disease_Homo sapiens_hsa05016 | 1.05460282 |
| 57 | Shigellosis_Homo sapiens_hsa05131 | 1.03636896 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.03444721 |
| 59 | Malaria_Homo sapiens_hsa05144 | 1.03394400 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02861324 |
| 61 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02445596 |
| 62 | Purine metabolism_Homo sapiens_hsa00230 | 1.02253930 |
| 63 | Long-term depression_Homo sapiens_hsa04730 | 1.00680065 |
| 64 | Asthma_Homo sapiens_hsa05310 | 1.00293804 |
| 65 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.99185994 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.98936728 |
| 67 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.98499310 |
| 68 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.98491028 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98132194 |
| 70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97637848 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.96073694 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.93512238 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.90581494 |
| 74 | Measles_Homo sapiens_hsa05162 | 0.90472744 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87254601 |
| 76 | Morphine addiction_Homo sapiens_hsa05032 | 0.85143771 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.83479098 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.81931016 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80750240 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.79811842 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79320048 |
| 82 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76142878 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75833841 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75813725 |
| 85 | Base excision repair_Homo sapiens_hsa03410 | 0.75204865 |
| 86 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.74470595 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73887242 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72883242 |
| 89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72682668 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72466840 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72309118 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72200285 |
| 93 | Mismatch repair_Homo sapiens_hsa03430 | 0.71879493 |
| 94 | Taste transduction_Homo sapiens_hsa04742 | 0.71688278 |
| 95 | Proteasome_Homo sapiens_hsa03050 | 0.71644173 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71509774 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69931965 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.69371983 |
| 99 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.68380053 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68187069 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68157492 |
| 102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67816066 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67550168 |
| 104 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.67544731 |
| 105 | Leishmaniasis_Homo sapiens_hsa05140 | 0.67320913 |
| 106 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66597780 |
| 107 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64949926 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64241916 |
| 109 | Spliceosome_Homo sapiens_hsa03040 | 0.64216459 |
| 110 | Amoebiasis_Homo sapiens_hsa05146 | 0.63749458 |
| 111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63733076 |
| 112 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61843231 |
| 113 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61131208 |
| 114 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.60001799 |
| 115 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59762866 |
| 116 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59265568 |
| 117 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58278624 |
| 118 | Salmonella infection_Homo sapiens_hsa05132 | 0.58040640 |
| 119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57552556 |
| 120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57492905 |
| 121 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56714848 |
| 122 | Lysosome_Homo sapiens_hsa04142 | 0.56157050 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.55810949 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55694596 |
| 125 | Histidine metabolism_Homo sapiens_hsa00340 | 0.55635452 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54445335 |
| 127 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53501928 |
| 128 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51384185 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51166469 |
| 130 | Pertussis_Homo sapiens_hsa05133 | 0.51142906 |
| 131 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.50930422 |
| 132 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50823968 |
| 133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50585692 |
| 134 | Insulin resistance_Homo sapiens_hsa04931 | 0.50175292 |
| 135 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50070866 |
| 136 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49389100 |
| 137 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49251651 |
| 138 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48952222 |
| 139 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48839507 |
| 140 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47020643 |
| 141 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46923562 |
| 142 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46504647 |
| 143 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45958906 |
| 144 | Melanoma_Homo sapiens_hsa05218 | 0.45800201 |
| 145 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.44506410 |
| 146 | Axon guidance_Homo sapiens_hsa04360 | 0.43424300 |
| 147 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42325765 |
| 148 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41272067 |
| 149 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.40266939 |
| 150 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.39975500 |
| 151 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39188199 |
| 152 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39113710 |
| 153 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37500287 |
| 154 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36540958 |
| 155 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36499978 |
| 156 | Platelet activation_Homo sapiens_hsa04611 | 0.35614691 |
| 157 | Tuberculosis_Homo sapiens_hsa05152 | 0.35490218 |
| 158 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35401864 |
| 159 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.29625282 |
| 160 | GABAergic synapse_Homo sapiens_hsa04727 | 0.28983736 |
| 161 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.28789072 |

